June 22 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES - NEW DATA SHOW THERATECHNOLOGIES' SORT1+ TECHNOLOGY IS EFFECTIVE IN MANY TREATMENT-RESISTANT CANCERS
* THERATECHNOLOGIES INC - INTENDS TO SUBMIT AN IND TO FDA FOR A FIRST -IN-HUMAN CLINICAL TRIAL FOR TH1902 BEFORE END OF 2020